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Mitochondrial DNA (mtDNA) sequence variation and maternal inheritance are valuable tools in assessing
ancestry of different human populations and for clinical practice. A new study (Wei et al., 2019) reports
that the fate of new mtDNA variants in the female germline is non-random as they report functional selection
and matching to nuclear ancestry to shape human mtDNA variation.The majority of cellular DNA resides in the
nuclear genome and is inherited equally
from both parents. However, mothers
contribute slightly more as 1% of DNA
is inherited directly from her via the
>100,000 mitochondrial DNA (mtDNA)
copies carried by the egg (Hutchison
et al., 1974). But before an oocyte is ready
to pass on its mtDNA load to the offspring,
it undergoes remarkable mitochondrial
remodeling. The mtDNA bottleneck of
the early female embryogenesis de-
creases the mtDNA copy number to
<100 copies by an unknown mechanism,
after which these mtDNAs are rapidly
replicated to reach the hundreds of thou-
sands of copies in the mature oocyte
(Shoubridge, 2000). The >1,000-fold in-
crease of mtDNA copies means that a
rare variant that survives the bottleneck
can become the major mtDNA type in
the mature egg and the offspring. By this
mechanism the mtDNA genotype can
shift within one generation (Figure 1).
Furthermore, in addition to the bottleneck,
the murine germline selects against dele-
terious mtDNA mutations (Stewart et al.,
2008), adding a further mechanism that
defines the final mtDNA content in the
egg. In mice, specific somatic tissues un-
dergo selection as well (Battersby et al.,
2003; Latorre-Pellicer et al., 2016). The
factors that shape human mtDNA varia-
tion have, however, been poorly known.
mtDNA encodes only 13 proteins and
the ribosomal and transfer RNAs for their
protein synthesis (Nunnari and Suomalai-
nen, 2012). Prime quality mtDNA is
essential for health, as over 200 mtDNA
mutations underlie a variety of human dis-
eases. In disorders, mutant mtDNA often
shows heteroplasmy; that is, mutantmtDNA coexists with the wild-type copies
in the same cell (Nunnari and Suomalai-
nen, 2012). Until recently, healthy people
were assumed to have only identical
mtDNA copies (i.e., homoplasmy).
However, in a newly published study,
Patrick Chinnery and his coworkers (Wei
et al., 2019), utilizing data from the British
NIHR BioResource and the 100,000
Genomes Project to study 12,975 whole-
genome sequences, including 1,526
mother-offspring pairs, found that almost
half showed mtDNA heteroplasmy at a
frequency greater than 1%. These results
imply that low-level mtDNA variation is
common in the human population.
The inclusion of families in the 100,000
Genome Project gave Wei et al. a unique
opportunity to study mother-offspring
pairs to explore what kind of mtDNA vari-
ants were inherited. They found that new
variants were often selected against,
whereas previously reported, tolerated
ones tended to increase in proportion,
suggesting selection against deleterious
variants. New mtDNA sequence variants
in coding regions and rRNA were under
the strictest selection, but also tRNA mu-
tations were selected against, different
from the data in mice (Stewart et al.,
2008). The data of Wei et al. of essential
mitochondrial rRNA sequences, still
poorly known in humans, are valuable for
interpretation of pathological changes
in the context of disease. Altogether, the
evidence suggests that mtDNA se-
quences and the mtDNA replication ma-
chinery go through a rigorous testing pro-
cess during oocyte maturation as these
sequences are squeezed throughabottle-
neck, quality-checked, and replicated
1,000-fold—a true survival of the fittest.Cell Metabolism 3Wei et al. inspected further a heated
topic in the mtDNA field. A recent study
reported evidence for paternal mtDNA in-
heritance in three families (Luo et al.,
2018). Those findings raised attention,
but also concerns, because biparental
mtDNA contribution would havemajor im-
plications for genetic counseling and for
timing in evolutionary studies. In their
100,000 Genomes data, Wei et al. identi-
fied 196 father-offspring pairs with low-
level mtDNA heteroplasmy. In one of
these, the child’s variant was absent in
the mother, but present in the father.
Despite the variant being common and
prone to occur de novo, the finding is
compatible with paternal mtDNA trans-
mission. The topic should be revisited in
other genome data resources, to estab-
lish the frequency of such events. These
data highlight the capacity of massive
population genome datasets to test and
validate experimental data raised from
smaller studies.
mtDNA does not work alone. Its 13 pro-
tein products assemble with over 90 nu-
clear-encoded proteins, orchestrated by
an army of assembly factors, to generate
the functional enzyme complexes of the
respiratory chain (Nunnari and Suomalai-
nen, 2012). The tight matching of the sub-
components within the cellular microma-
chines is essential to prevent premature
electron leak and reaction with oxygen,
which would generate highly reactive and
potentially damaging oxygen radicals.
The match is best achieved if the compo-
nents stem from one type of genome,
whichmay be the reason evolution favored
uniparental inheritance in the vast majority
of species. In mice, mtDNA variants have
been suggested to follow nuclear genome0, August 6, 2019 ª 2019 Elsevier Inc. 231
Figure 1. Mitochondrial DNA Bottleneck
Selective forces acting onmitochondrial DNA during oocyte development and
fetal development. Green mitochondria carry mtDNA that provides selective
advantage; gray mitochondria carry mtDNA that is selected against.
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et al., 2016), but no evidence
for this process exists in hu-
mans. Wei et al. provide
exciting data pointing to co-
evolution. Again, in their




clear ancestry. For example, if
awomanofAsiandescenthas
offspring with a man of Euro-
pean descent, their children’s
mtDNA,which used tocoexist
only with an Asian nuclear
genome background, now
co-operates in the same cell
with European nuclear
genome. In this scenario, dur-
ing subsequent generations,
the nuclear genes become
increasingly European, but inthe maternal line mtDNA remains of Asian
origin. Intriguingly, the authors noticed
that new mtDNA variants tend to shift to-
ward the nuclear ancestry. The authors
propose that the shifting variants often
were predicted to have functional effects,
raising a possibility that the capacity for
ATP synthesismight drive selection. These
data suggest that the maternal germline
works as a busy match-maker, selecting
the mtDNA variants that best interact with
their nuclear counterparts.
The report raises important issues for
studies utilizing mtDNA variation to assess
human population history. Tominimize the
effect of functional selection, the variants
that occur in regions that tolerate changes,
preferably synonymous, are themost likely
to show linear inheritance. The tendency of
mtDNA toshift toward thenuclear ancestry
is important to consider when designing
mitochondrial transfer therapies, aiming
to replace the patient’s mtDNA with
healthy donor mtDNA (Craven et al.,
2010). The finding supports use of donors
with mtDNA haplotype match.
The study also raises questions that
remain to be solved. Why is low-level
heteroplasmy so common in people?
Perhaps it provides a pool of mtDNAs
that continuously ‘‘probe’’ potential for232 Cell Metabolism 30, August 6, 2019evolution and improved nuclear match-
ing. Because of the selective mtDNA
bottleneck, beneficial variants could
amplify and secure the best mitochon-
drial respiratory machinery for the
offspring (Figure 1). Furthermore, patho-
logical mtDNA mutations do exist, even
ones compromising viability soon after
birth. How do they leak through the
selection?
A few critical points deserve further
consideration. Wei et al. extrapolate their
conclusions on germline functions from
analyzing blood DNA, but they do not
discuss the fact that in mice some tissues
select for different mtDNA genotypes in a
heteroplasmic situation (Battersby et al.,
2003; Latorre-Pellicer et al., 2016). In hu-
mans, leukocytes are known to select
against specific mtDNA variants, such as
m.3243A>G (Rahman et al., 2001), which
Wei et al. report to show a negative shift.
Therefore, the conservative conclusion
is that the observed selective forces
occur at some point between the female
germline and the sampled blood. Hope-
fully, though, as the extent of tissue bio-
banks increases, this question of how
representative blood DNA is for other tis-
sues, including the germline, will be
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